Literature DB >> 7642800

Expression of trk receptors in the developing and adult human central and peripheral nervous system.

Y Muragaki1, N Timothy, S Leight, B L Hempstead, M V Chao, J Q Trojanowski, V M Lee.   

Abstract

A family of tyrosine receptor kinases known collectively as trk receptors plays an essential role in signal transduction mediated by nerve growth factor and related neurotrophins. To localize the major trk receptors (trkA, B and C) in the developing and adult central (CNS) and peripheral (PNS) nervous system, we generated monoclonal antibodies (MAbs) to extracellular (MAbs E7, E13, E16, E21, E29) and intracellular (MAb I2) domains of human trkA fused to glutathione S-transferase. Several MAbs (E7, E13, E16) recognized glycosylated trkA (gp140trk and gp110trk) in Western blots, one MAb (E7) recognized non-glycosylated (p80trk) and glycosylated trkA in immunoprecipitation assays, and two MAbs (E13, E29) detected trkA on the cell surface of NIH3T3 cells transfected with a trkA cDNA. Although generated to trkA fusion proteins, this panel of MAbs also recognized trkB and trkC in flow cytometric studies of NIH3T3 cells transfected with trkB or trkC cDNAs. Thus, we used these pan-trk MAbs to probe selected regions of the CNS and PNS including the hippocampus, nucleus basalis of Meynert, cerebellum, spinal cord, and dorsal root ganglion (DRG) to localize trkA, B, and C receptors in the developing and adult human nervous system. These studies showed that trk receptors are expressed primarily by neurons and are detectable very early in the developing hippocampus, cerebellum, spinal cord, and DRG. Although the distribution and intensity of trk immunoreactivity changed with the progressive maturation of the CNS and PNS, immunoreactive trk receptors were detected in neurons of the adult human hippocampus, nucleus basalis of Meynert, cerebellum, spinal cord, and DRG. This first study of trk receptor proteins in the developing and adult human CNS and PNS documents the expression of these receptors in subsets of neurons throughout the developing and adult nervous system. Thus, although the expression of trk receptor proteins is developmentally regulated, the constitutive expression of these neurotrophin receptors by neurons in many regions of the adult human CNS and PNS implies that mature trk receptor-bearing neurons retain the ability to respond to neurotrophins long after terminal neuronal differentiation is complete.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7642800     DOI: 10.1002/cne.903560306

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  19 in total

1.  Neuroprotection signaling pathway of nerve growth factor and brain-derived neurotrophic factor against staurosporine induced apoptosis in hippocampal H19-7/IGF-IR [corrected].

Authors:  Truong L X Nguyen; Chung Kwon Kim; Jun-Hee Cho; Kyung-Hoon Lee; Jee-Yin Ahn
Journal:  Exp Mol Med       Date:  2010-08-31       Impact factor: 8.718

2.  Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor.

Authors:  M Cazorla; J M Arrang; J Prémont
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

3.  An Immortalized Human Dorsal Root Ganglion Cell Line Provides a Novel Context To Study Herpes Simplex Virus 1 Latency and Reactivation.

Authors:  Nikki M Thellman; Carolyn Botting; Zachary Madaj; Steven J Triezenberg
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

4.  Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury.

Authors:  R Grill; K Murai; A Blesch; F H Gage; M H Tuszynski
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

5.  BDNF-promoted increases in proximal dendrites occur via CREB-dependent transcriptional regulation of cypin.

Authors:  Munjin Kwon; José R Fernández; Gregory F Zegarek; Sean B Lo; Bonnie L Firestein
Journal:  J Neurosci       Date:  2011-06-29       Impact factor: 6.167

Review 6.  Experimental neurotrophic factor therapy leads to cortical synaptic remodeling and compensates for behavioral deficits.

Authors:  A C Cuello
Journal:  J Psychiatry Neurosci       Date:  1997-01       Impact factor: 6.186

7.  Expression of mRNAs for neurotrophins (NGF, BDNF, and NT-3) and their receptors (p75NGFR, trk, trkB, and trkC) in human peripheral neuropathies.

Authors:  G Sobue; M Yamamoto; M Doyu; M Li; T Yasuda; T Mitsuma
Journal:  Neurochem Res       Date:  1998-06       Impact factor: 3.996

8.  Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex.

Authors:  S D Croll; C Suri; D L Compton; M V Simmons; G D Yancopoulos; R M Lindsay; S J Wiegand; J S Rudge; H E Scharfman
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

9.  A zwitterionic near-infrared dye linked TrkC targeting agent for imaging metastatic breast cancer.

Authors:  Zhen Yang; Syed Muhammad Usama; Feng Li; Kevin Burgess; Zheng Li
Journal:  Medchemcomm       Date:  2018-08-03       Impact factor: 3.597

10.  Distinct effects on the dendritic arbor occur by microbead versus bath administration of brain-derived neurotrophic factor.

Authors:  Kate M O'Neill; Munjin Kwon; Katherine E Donohue; Bonnie L Firestein
Journal:  Cell Mol Life Sci       Date:  2017-07-11       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.